🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT07313839
Recruiting Not applicable

Comparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial)

NCT07313839 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-10-07
Last updated
2026-06-17

Condition(s) studied

Gynecologic CancersVaginal Cuff DehiscencePostoperative Complications

Investigational drug(s) / intervention(s)

Double-Layer Vaginal Vault Closure with Self-Locking SutureDouble-Layer Vaginal Vault Closure with Polyglactin 910

Double-Layer Vaginal Vault Closure with Self-Locking Suture: Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with a self-locking (barbed) suture following hysterectomy.

Double-Layer Vaginal Vault Closure with Polyglactin 910: Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with traditional braided Polyglactin 910 suture following hysterectomy.

Study summary

Vaginal vault closure after laparoscopic or robotic hysterectomy may be associated with postoperative complications such as vaginal cuff dehiscence, infection, and bleeding. The optimal suture material and technique for laparoscopic colporrhaphy, particularly in patients undergoing surgery for gynecologic malignancies, remain controversial.

The BI-SURE trial is a multicenter, randomized controlled study designed to compare double-layer self-locking sutures versus double-layer traditional Polyglactin 910 sutures for laparoscopic vaginal vault closure after hysterectomy. The study aims to evaluate postoperative effectiveness and safety within three months after surgery.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing laparoscopic or robotically assisted hysterectomy for gynecologic malignant disease * Age ≥ 18 years * Ability to provide written informed consent Exclusion Criteria: * Laparotomic or vaginal hysterectomy * Contraindication to laparoscopic vaginal vault closure

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Department of Medicine and Surgery, University Hospital of Parma Parma Italy Recruiting
Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Bologna Italy Not Yet Recruiting
Department of Obstetrics and Gynecology, Ospedale Santa Croce e Carle, Cuneo, Italy. Cuneo Italy Recruiting
Department of Gynecologic Oncology. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Milan Italy Not Yet Recruiting
Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. Udine Italy Not Yet Recruiting

More Azienda Ospedaliero-Universitaria di Parma trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07313839 on ClinicalTrials.gov ↗ ← All trials in Italy